Diagenode licenses new ChIPmentation technology for low input library preparation for ChIP-sequencing

Diagenode’s new agreement with the CeMM Research Center of Molecular Medicine of the Austrian Academy of Sciences will enable ChIP-sequencing from low input and difficult samples Denville, NJ, USA Liège, Belgium – Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, has licensed a new technology specific for ChIP-sequencing from [...]

908 Devices Introduces Next-Generation HPMS Device for the First Responder Community

MX908 brings enhanced detection and identification capabilities to modern-day response missions BOSTON -- 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced the release of MX908™, a second-generation handheld chemical detection and identification device powered by the Company’s patented and award-winning high-pressure mass spectrometry (HPMS™) technology. Designed for true trace-level detection [...]

Horizon Discovery Announces Progress of its Gene and Cell Therapy Platform for Contract Service and Therapeutic Applications

Platform comprises Horizon’s viral, nuclease and transposon gene editing technologies for research and development Three new contract wins contributing a value of more than $2 million in 2017 with potential for long-term alliance development Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or “the Company”), the world leader in the application of gene editing [...]

Launch of next generation stain-free gel imaging system

Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to introduce its NuGenius+ gel imaging system. This cost-effective system is configured with powerful new software for generating accurate, high quality images of stain-free protein gels, in addition to DNA agarose and SDS- PAGE gels, saving scientists valuable time with their research. Featuring [...]

Twist Bioscience Raises Additional $27 Million

-- Aggregate New Funding in 2017 Reaches $60 Million; Total of $191 Million Raised Since Inception – -- Accelerates Growth into Drug Discovery, Supports Investment in DNA Data Storage – SAN FRANCISCO, Calif. – Twist Bioscience Corporation, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it raised an additional [...]

Malvern Panalytical opens new application lab

Almelo, the Netherlands Malvern Panalytical, one of the world’s leading suppliers of analytical instrumentation and software, opened their totally refurbished application lab at the Almelo headquarters at Lelyweg 1 on July 6th. The entire international management was present on this day. Since 1 January 2017, PANalytical has merged its activities with UK-based sister company Malvern [...]

PANalytical donates for Save the Children foundation

Almelo, the Netherlands PANalytical, one of the world’s leading suppliers of analytical instrumentation, presented a ‘cheque’ representing €8,500 to Ms. Sarah Clifton and Ms. Chris Ochtrup from the Save the Children foundation. This substantial donation was generated by the most recent PANalytical Global Customer Satisfaction Survey whereby PANalytical donates €5 to charity for every completed [...]

BERKELEY LIGHTS ANNOUNCES CELL LINE DEVELOPMENT PROGRAM

Emeryville, CA – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today a pilot cell line development program with Shire.  Under the program, BLI will install a Beacon™ optofluidic platform at Shire’s facility to validate the time and cost savings associated with the Beacon’s cell line development [...]

Advancing the pace of NGS: Accelerating the deployment of precision medicine capabilities

How a leading academic hospital is analyzing complex clinical data and uncovering new medical insights with powerful precision medicine solution, QIAGEN Clinical Insight. Next-generation sequencing (NGS) creates transformative opportunities to expand our understanding of biomedicine, reshape clinical care, and improve human health. NGS also opens broad vistas for innovation and technology. At the University of [...]

LabConnect, Inc., Announces $24.5 Million in Series A Funding

Company’s strong growth and technical expertise in managing clinical trials attracts growth equity investment SEATTLE----LabConnect, a leading provider of highly customized global central laboratory and support services to biopharmaceutical, medical device, and contract research organizations (CROs), announced today a $24.5 million Series A investment by ABS Capital Partners, a leading late-stage growth company investor, Pablo [...]

Access IBO on Knowledge Center